Huda R M Rashdan

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Molecules (Basel, Switzerland)

RSC advances

Pharmaceuticals (Basel, Switzerland)

ACS omega

National Research Centre

Ain Shams University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Research Centre

Egypt

Researcher :: Chemistry of natural and microbial products

Education History

Ain Shams University

Egypt

PHD :: chemistry

Cairo University

Egypt

MSC :: chemistry

Publications

Amal O A Ibrahim, Abdelfattah Hassan, Ahmed M Mosallam, Ahmed Khodairy, Huda R M Rashdan, Aboubakr Haredi Abdelmonsef
New quinazolin-2,4-dione derivatives incorporating acylthiourea, pyrazole and/or oxazole moieties as antibacterial agents via DNA gyrase inhibition. RSC advances 14 (24) (2024)
Huda R M Rashdan, Mohamad Taha Abdelrahman, Anna Chiara De Luca, Maria Mangini
Towards a New Generation of Hormone Therapies: Design, Synthesis and Biological Evaluation of Novel 1,2,3-Triazoles as Estrogen-Positive Breast Cancer Therapeutics and Non-Steroidal Aromatase Inhibitors. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Huda R M Rashdan, Mohamad Taha Abdelrahman, Anna Chiara De Luca, Maria Mangini
Towards a New Generation of Hormone Therapies: Design, Synthesis and Biological Evaluation of Novel 1,2,3-Triazoles as Estrogen-Positive Breast Cancer Therapeutics and Non-Steroidal Aromatase Inhibitors. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Huda R M Rashdan, Mohamad Taha Abdelrahman, Anna Chiara De Luca, Maria Mangini
Towards a New Generation of Hormone Therapies: Design, Synthesis and Biological Evaluation of Novel 1,2,3-Triazoles as Estrogen-Positive Breast Cancer Therapeutics and Non-Steroidal Aromatase Inhibitors. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Amal O A Ibrahim, Abdelfattah Hassan, Ahmed M Mosallam, Ahmed Khodairy, Huda R M Rashdan, Aboubakr Haredi Abdelmonsef
New quinazolin-2,4-dione derivatives incorporating acylthiourea, pyrazole and/or oxazole moieties as antibacterial agents via DNA gyrase inhibition. RSC advances 14 (24) (2024)
Huda R M Rashdan, Gharieb S El-Sayyad, Ihsan A Shehadi, Aboubakr Haredi Abdelmonsef
Antimicrobial Potency and E. coli β-Carbonic Anhydrase Inhibition Efficacy of Phenazone-Based Molecules. Molecules (Basel, Switzerland) 28 (22) (2023)
Mohamed Abdelraof, Mohamed Fikry, Amr H Hashem, Mehrez E El-Naggar, Huda R M Rashdan
Insight into novel anti-mucormycosis therapies: investigation of new anti-mucormycosis laser-induced photodynamic therapy based on a sulphone bis-compound loaded silica nanoemulsion. RSC advances 13 (30) (2023)
Mohamed El-Naggar, Huda R M Rashdan, Aboubakr Haredi Abdelmonsef
Cyclization of Chalcone Derivatives: Design, Synthesis, In Silico Docking Study, and Biological Evaluation of New Quinazolin-2,4-diones Incorporating Five-, Six-, and Seven-Membered Ring Moieties as Potent Antibacterial Inhibitors. ACS omega 8 (30) (2023)
Huda R M Rashdan, Mohamad Taha Abdelrahman, Ihsan A Shehadi, Sara S El-Tanany, Bahaa Ahmed Hemdan
Novel Thiadiazole-Based Molecules as Promising Inhibitors of Black Fungi and Pathogenic Bacteria: In Vitro Antimicrobial Evaluation and Molecular Docking Studies. Molecules (Basel, Switzerland) 27 (11) (2022)
Aboubakr Haredi Abdelmonsef, Mohamed Omar, Huda R M Rashdan, Mohamed M Taha, Ahmed M Abobakr
Design, synthetic approach, in silico molecular docking and antibacterial activity of quinazolin-2,4-dione hybrids bearing bioactive scaffolds. RSC advances 13 (1) (2022)
Ihsan A Shehadi, Mohamad Taha Abdelrahman, Mohamed Abdelraof, Huda R M Rashdan
Solvent-Free Synthesis, In Vitro and In Silico Studies of Novel Potential 1,3,4-Thiadiazole-Based Molecules against Microbial Pathogens. Molecules (Basel, Switzerland) 27 (2) (2022)
Mehrez E El-Naggar, Emad K Radwan, Huda R M Rashdan, Shaimaa T El-Wakeel, Asmaa A Koryam, Ahmed Sabt
Simultaneous removal of Pb 2+ and direct red 31 dye from contaminated water using N -(2-hydroxyethyl)-2-oxo-2 H -chromene-3-carboxamide loaded chitosan nanoparticles. RSC advances 12 (29) (2022)
Aboubakr Haredi Abdelmonsef, Mohamed Omar, Huda R M Rashdan, Mohamed M Taha, Ahmed M Abobakr
Design, synthetic approach, in silico molecular docking and antibacterial activity of quinazolin-2,4-dione hybrids bearing bioactive scaffolds. RSC advances 13 (1) (2022)
Huda R M Rashdan, Ihsan A Shehadi, Mohamad Taha Abdelrahman, Bahaa Ahmed Hemdan
Antibacterial Activities and Molecular Docking of Novel Sulfone Biscompound Containing Bioactive 1,2,3-Triazole Moiety. Molecules (Basel, Switzerland) 26 (16) (2021)
Huda R M Rashdan, Aboubakr Haredi Abdelmonsef, Mortaga M Abou-Krisha, Tarek A Yousef
Synthesis, Identification, Computer-Aided Docking Studies, and ADMET Prediction of Novel Benzimidazo-1,2,3-triazole Based Molecules as Potential Antimicrobial Agents. Molecules (Basel, Switzerland) 26 (23) (2021)
Huda R M Rashdan, Mohamed El-Naggar, Aboubakr Haredi Abdelmonsef
Synthesis, Molecular Docking Studies and In Silico ADMET Screening of New Heterocycles Linked Thiazole Conjugates as Potent Anti-Hepatic Cancer Agents. Molecules (Basel, Switzerland) 26 (6) (2021)
Huda R M Rashdan, Mohammad M Farag, Marwa S El-Gendey, Marwa M Mounier
Toward Rational Design of Novel Anti-Cancer Drugs Based on Targeting, Solubility, and Bioavailability Exemplified by 1,3,4-Thiadiazole Derivatives Synthesized Under Solvent-Free Conditions. Molecules (Basel, Switzerland) 24 (13) (2019)

Huda R M Rashdan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Huda R M Rashdan